05/15/2026 00:00
ACI Worldwide and Security Bank Philippines Set New Benchmark for Enterprise-wide Payments Modernization

ACI Worldwide (NASDAQ: ACIW), an original innovator in global payments technology, and Security Bank Corporation (Security Bank), a leading universal bank in the Philippines, today announced that they won the "Best Payment Technology Initiative in Asia Pacific" at The Asian Banker (TAB) Global Financial Technology Innovation Awards 2026. This award recognizes Security Bank and ACI Worldwide’s transformation of payment infrastructure by consolidating fragmented systems into a unified, scalable p...

05/22/2026 09:18
Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 2026

Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selective RET inhibitor (SRI),...

05/15/2026 01:00
Meiji Seika Pharma: Positive Results from the Phase III Integral-1 Trial of Nacubactam, a Novel β-Lactamase Inhibitor, in Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis ― Published in The Lancet

Meiji Seika Pharma Co., Ltd. (headquartered in Tokyo; President and Representative Director: Toshiaki Nagasato) today announced that the results of the Integral-1 study, one of two global Phase III clinical trials evaluating the efficacy and safety of its novel β-lactamase inhibitor nacubactam (development code: OP0595), have been published in The Lancet. The article is entitled “---Efficacy and safety of cefepime–nacubactam and aztreonam–nacubactam compared with imipenem–cilastatin for complic...

05/25/2026 06:00
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation...

05/15/2026 02:00
FPT Secures Triple Wins at the 2026 Globee® Awards for Artificial Intelligence

Global IT Corporation FPT has secured three wins at the 2nd Annual 2026 Globee® Awards for Artificial Intelligence, a global awards program honoring achievements in AI, machine learning, automation, and AI-driven innovation across industries and organizations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260514201554/en/ Its solutions were recognized in the following categories: Silver Globee® Winner for Intelligent Chatbot &am...

AFP at Paris Photo

Three photographs by Eric Schwab from the AFP Collection to be exhibited at Paris Photo, the world’s biggest international photography fair, from November 13 to 16, 2025, at the Grand Palais.

Three photographs by Eric Schwab from the AFP Collection to be exhibited at Paris Photo, the world’s biggest international photography fair, from November 13 to 16, 2025, at the Grand Palais.
Anglais
03/26/2026 08:58
LTM Positioned as a Leader in ISG’s Provider Lens™ Evaluation for Oracle Cloud and Technology Ecosystem 2025

LTM, the Business Creativity partner to the world’s largest enterprises, has been recognized as a Leader in multiple quadrants in the ISG Provider Lens™ Oracle Cloud and Technology Ecosystem 2025 reports for both the United States and Europe by Information Services Group (ISG), a leading global technology research and advisory firm. The ISG Provider Lens™ study evaluates leading Oracle ecosystem service providers across critical capability areas, including: Professional Services Managed...